Serum conversion pattern of SCC-Ag levels between pre- and post-chemoradiotherapy predicts recurrence and metastasis in cervical cancer: a multi-institutional analysis

MLA

Mina Yu, et al. “Serum Conversion Pattern of SCC-Ag Levels between Pre- and Post-Chemoradiotherapy Predicts Recurrence and Metastasis in Cervical Cancer: A Multi-Institutional Analysis.” Clinical & Experimental Metastasis, vol. 38, Aug. 2021, pp. 467–74. EBSCOhost, https://doi.org/10.1007/s10585-021-10115-w.

APA

Mina Yu, Yeon-Sil Kim, Songmi Jeong, Sung Jong Lee, Jong Hoon Lee, Sea-Won Lee, Ji Hyung Hong, & Sung Hwan Kim. (2021). Serum conversion pattern of SCC-Ag levels between pre- and post-chemoradiotherapy predicts recurrence and metastasis in cervical cancer: a multi-institutional analysis. Clinical & Experimental Metastasis, 38, 467–474. https://doi.org/10.1007/s10585-021-10115-w

Chicago

Mina Yu, Yeon-Sil Kim, Songmi Jeong, Sung Jong Lee, Jong Hoon Lee, Sea-Won Lee, Ji Hyung Hong, and Sung Hwan Kim. 2021. “Serum Conversion Pattern of SCC-Ag Levels between Pre- and Post-Chemoradiotherapy Predicts Recurrence and Metastasis in Cervical Cancer: A Multi-Institutional Analysis.” Clinical & Experimental Metastasis 38 (August): 467–74. doi:10.1007/s10585-021-10115-w.